Stay updated on Lenvatinib and Pembrolizumab in HCC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in HCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record with a minimal error screen and navigation header.
    Difference
    18%
    Check dated 2026-09-19T22:27:11.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    An NIH funding note '2018 ( U.S. NIH Grant/Contract )' was added and a new page revision tag 'Revision: v3.6.6' was introduced, while the 'Plain Language Summary' and the previous revision tag 'Revision: v3.6.5' were removed.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:08.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a new build of the site.
    Difference
    0.0%
    Check dated 2026-08-08T18:21:06.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, signaling a small page-level update. This change does not alter trial details or user-facing features.
    Difference
    0.0%
    Check dated 2026-07-25T10:30:03.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.2 to v3.6.3, indicating a minor update to the page's template or metadata. This appears to be an internal version bump rather than a change to study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-07-03T21:53:38.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.2. This reflects a minor update to the page content rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-26T23:09:56.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in HCC Clinical Trial page.